Claim · 2023-07-12 · announcement · Stated in source · Supported

Recursion announced on 12 July 2023 a $50 million investment by NVIDIA, executed as a private investment in public equity (PIPE).

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

NVIDIA → announced investment in → Recursion Pharmaceuticals

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

NVIDIAannounced investment in ↓Recursion Pharmaceuticals

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source

Date: 2023-07-12 · announcement Records dated 2023 →
Stage: announced
Amount: exact · $50,000,000
transaction

Scope and limitsRecursion's announcement; the record does not establish the number of shares, the price or the settlement. The amount is the stated amount of this PIPE investment by NVIDIA, not a valuation.

The evidence 01

primary sourceSupports the claim

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

Recursion Pharmaceuticals, Inc. (Exhibit 99.1 to Form 8-K) · 2023-07-12

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“today announced a $50 million investment by NVIDIA, which was executed as a private investment in public equity (PIPE).”

Location in source first paragraph

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Recursion Pharmaceuticals, Inc. (Exhibit 99.1 to Form 8-K)
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 7e670958d0987c0c50a7432a89091bdc6ca094d02da274eb6bc8774111b9bab7). Exhibit 99.1 to Form 8-K filed 2023-07-12, accession 0001601830-23-000050, as served by SEC EDGAR on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Recursion Pharmaceuticals, Inc. (Exhibit 99.1 to Form 8-K), “Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery”, 2023-07-12.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (19 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. A counterparty announced an investment. Amount and transaction stage are qualified separately. From schema 2.21 the investor may be a public body.

Date. Date of Recursion's press release.

Record ID aib-co-nvidia-recursion-investment-2023